Articles On Capitol Health (ASX:CAJ)

Analysts at Macquarie believe there are several significant tailwinds for ASX All Ords healthcare stock Integral Diagnostics Ltd (ASX: IDX) in the coming year, and have a bullish price target on the company's shares. Integral Diagnostics...

The small side of the market has come under pressure recently amid increased volatility. While this is disappointing, it could have created a buying opportunity for investors with a high tolerance for risk. But which small cap ASX shares co...

Integral Diagnostics and Medadvisor have new CEOs after the latest round of changes at the top Mayne’s refrain: let the Takeovers Panel decide It’s a case of the MEGnificent Five as Compumedics sells another brain-scanning device in China...

Integral Diagnostics Ltd (ASX: IDX) shares are significantly undervalued, broker Bell Potter says, with total returns of more than 50% achievable over the next 12 months. The broker has a bullish price target of $4 per share on the imagi...

Strong growth in healthcare service provision in August signals good news for healthcare stocks, with Macquarie analysts tipping Integral Diagnostics Ltd (ASX: IDX) shares to pile on more than 20% in gains. Medicare statistics for Augu...

If you are looking for investment ideas, then it could pay to listen to what Bell Potter is saying. That's because the broker has just released its latest top Australian picks for the month of September. It notes that its panel of favoured...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A summary of the highlights from Broker Call Extra updates throughout the week past...

Argenica shares fall on phase II trial results, but management says drug appears effective in an important patient sub-group 4D Medical shares soar on reimbursement news What’s up doc? Dunno, we don’t go there   Argenica Therapeutics (ASX...

Nanosonics shares gain up to 14% on better-than-expected numbers Investors applaud the early days of the Integral Diagnostics/Capitol Health merger Firebrick Pharma extends the reach of its nasal germ-buster Device maker Nanosonics (ASX:N...

If you have a high tolerance for risk and are on the hunt for big returns, then look no further. That's because analysts at Bell Potter have named the two small cap ASX shares listed below as buys with potential to deliver outsized returns....

ASX small-cap shares can be exciting ideas if they have good growth potential. Businesses with smaller market capitalisations aren't followed by as many fund managers or brokers, so there's a higher chance they're undervalued by the mar...

A key FDA quality control lab will remain open, while a judge halts DOGE’s plans to cull billions of research grants Cochlear and Resmed win an upgrade after their post-results share thumping Dissident holder sells out after Percheron CEO...

The Integral Diagnostics Ltd (ASX: IDX) share price is having a day to forget on Wednesday. In morning trade, the ASX healthcare stock is down 30% to $2.00. This follows the release of the medical imaging services provider's half year resul...

Looking to buy a few ASX small-cap shares to potentially help turbocharge your portfolio returns in 2025? Then Lucas Goode, a portfolio manager for the IML Australian Smaller Companies Fund, has three companies you may wish to run your slid...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor As is custom this time of the year, f...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Greg Peel Pending MRI deregulation is behind the now approved merger of Integral Diagnosti...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US Equities had a weak session, but nothing like the growth stocks sell-off that occ...

Integral Diagnostics (ASX:IDX), which operates diagnostic imaging services in Australia and New Zealand, has secured clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed acquisition of Capitol Health (AS...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Highlights ASX 200 closes 0.1% lower at 8,436.2 after early losses. Webjet Group WEB and Maas Group MGH post strong rallies. Star Entertainment SGR remains flat after a downgrade. The Australian share market ended Friday's trading...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Jarden upgrades Integral Diagnostics after merger insights The broker highlights growth opportunities in imaging sector Australia’s deregulation boosts MRI access and revenue potential   The imaging sector is by no means the sexiest part...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

  US stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new all-time highs, as traders cheered the Federal Reserve’s Wednesday decision to lower interest rates by half a percentage point. The 30-sto...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8210.00 + 73.00 0.90% S&P ASX 200 8191.90 +...

US stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new all-time highs, as traders cheered the Federal Reserve’s Wednesday decision to lower interest rates by half a percentage point. The 30-stock...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

ASX healthcare stocks showed mixed results following the release of their most recent financials on Tuesday. Three companies in particular stand out, with two finishing in the green and one in the red. Integral Diagnostics Ltd (ASX: I...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ACF)) - Acrow...

As the 2024 fiscal year reporting season progresses, several key players across different sectors have revealed their financial performance, showcasing a mix of resilience and challenges. Diagnostic imaging provider Capitol Health, energy c...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7995.00 + 30.00 0.38% S&P ASX 200 8010.50 +...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Highlights:  ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global economic updates.  Big Tech stocks showed mixed results overnight, with Meta and Nvidia gaining, while Apple, Alphabet, and Amazon decline...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Looking for exposure to the healthcare sector in FY 2025? If you are, then check out the three ASX shares listed below. They have just been tipped as Bell Potter's top healthcare stocks to buy now: Aroa Biosurgery Ltd (ASX: ARX) Aroa Biosu...

World Overnight SPI Overnight 7775.00 + 26.00 0.34% S&P ASX 200 7759.60 – 23.40 – 0.30% S&P500 5482.87 + 4.97 0.09% Nasdaq Comp 17858.68 + 53.53 0.30% DJIA 39164.06 + 36.26 0.09% S&P500 VIX 12.24 – 0.31 – 2.47% U...

The S&P/ASX 200 Index (ASX: XJO) is having a tough time on Wednesday after a stronger than expected inflation reading. In afternoon trade, the benchmark index is down 1% to 7,758.4 points. Four ASX shares that are not letting that hold...

Race Oncology Ltd (ASX: RAC) shares burst out of the gates on Wednesday morning. In early trade, the ASX healthcare stock was up as much as 15% to $1.96. The clinical stage biopharmaceutical company's shares have eased back a touch since th...

With the S&P/ASX 200 Health Care Index (ASX: XHJ) dipping slightly into the red on Wednesday, it's been a different story for three individual ASX healthcare shares. Pro Medicus Limited (ASX: PME), Race Oncology Ltd (ASX: RAC), and...

S&P/ASX 200 Index (ASX: XJO) gold stocks enjoyed a blistering rally from late February through to late May this year. That rally was driven by a surge in the gold price. On 28 February, the yellow metal was trading for US$2,030 per oun...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday and storming higher. In afternoon trade, the benchmark index is up 0.95% to 7,773.6 points. Four ASX shares that are rising more than most today are listed below. Here's why t...

The S&P/ASX All Ordinaries Index (ASX: XAO) is up 0.76% to 8,003.8 points in early trading on Tuesday. As reported in The Australian, 3 All Ords stocks have just gained buy ratings from top brokers. Let's check them out. Capst...

Integral Diagnostics and Capitol Health have agreed to join forces and create a 155-clinic diagnostic imaging company.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,711.6 points. Four ASX shares that are falling more than most today are listed...

The market may be edging lower on Monday but that hasn't stopped one ASX All Ords stock from rocketing. In morning trade, the Capitol Health Ltd (ASX: CAJ) share price is up 20% to 29.5 cents. Why is this ASX All Ords stock rocketing? Inves...